TrianglePUBLICATIONS · 22421195
Phase I study of vincristine, irinotecan, and ¹³¹I-metaiodobenzylguanidine for patients with relapsed or refractory neuroblastoma: a new approaches to neuroblastoma therapy trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Clin Cancer Res
- Publication date
- 2012 May 1
- First author
- DuBois SG
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- DuBois SG
- type
- Author
- name
- Chesler L
- type
- Author
- name
- Groshen S
- type
- Author
- name
- Hawkins R
- type
- Author
- name
- Goodarzian F
- type
- Author
- name
- Shimada H
- type
- Author
- name
- Yanik G
- type
- Author
- name
- Tagen M
- type
- Author
- name
- Stewart C
- type
- Author
- name
- Mosse YP
- type
- Author
- name
- Maris JM
- type
- Author
- name
- Tsao-Wei D
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- DuBois SG
- type
- Author
- name
- Chesler L
- type
- Author
- name
- Groshen S
- type
- Author
- name
- Hawkins R
- type
- Author
- name
- Goodarzian F
- type
- Author
- name
- Shimada H
- type
- Author
- name
- Yanik G
- type
- Author
- name
- Tagen M
- type
- Author
- name
- Stewart C
- type
- Author
- name
- Mosse YP
- type
- Author
- name
- Maris JM
- type
- Author
- name
- Tsao-Wei D
- type
- Author
- bibliography ids
- nci-bib-1fbd870febd4b927295420a3
- book metadata
- content sha256
- efa8ef4df98bdb6e84deffbed97840f56e8d4e5269690628301a514586845ad6
- document type
- citation
- dois
- 10.1158/1078-0432.CCR-11-3201
- electronic publication date
- display
- 2012 Mar 15
- precision
- day
- year
- 2012
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:22421195
- immutable id
- pubmed:22421195@efa8ef4df98bdb6e84deffbed97840f56e8d4e5269690628301a514586845ad6
- journal
- abbreviation
- Clin Cancer Res
- issn electronic
- 1557-3265
- issn print
- 1078-0432
- issue
- 9
- name
- Clinical cancer research : an official journal of the American Association for Cancer Research
- nlm unique id
- 9502500
- pages
- 2679-86
- volume
- 18
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 22421195
- provenance
- batch id
- c95be1d0b8cf19942816
- provider
- NCBI PubMed ESummary
- record sha256
- 8a3179e785b080502587fc44ac96a709fe640fe60e1ebad88d309bb914a2317c
- response sha256
- a96bb680a8f3690267e009557d1b07aab71455ba44aeba18695d98a3eeb5fcf2
- retrieved at
- 2026-09-09T23:46:47.691937+00:00
- publication date
- display
- 2012 May 1
- precision
- day
- year
- 2012
- publication types
- Clinical Trial, Phase I
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase I study of vincristine, irinotecan, and ¹³¹I-metaiodobenzylguanidine for patients with relapsed or refractory neuroblastoma: a new approaches to neuroblastoma therapy trial.
Preserved source evidence · Not medical advice